Get started
Author

Michael D. Richter

Observed names: M. Richter, M.D. Richter, Michael D Richter, Michael Richter
ORCID: 0000-0002-2702-1237
Observed ORCID: 0000-0002-2702-1237
OpenAlex ID: A5065282140
Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single‐Center Cohort of Sixty‐One Patients
2018 · Michael D. Richter, Cynthia Crowson, et al. · Arthritis & Rheumatology · 149
Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience
2018 · Michael D. Richter, Olga Pinkston, et al. · Arthritis & Rheumatology · 115
Orthopedic Surgery Among Patients With Rheumatoid Arthritis: A Population‐Based Study to Identify Risk Factors, Sex Differences, and Time Trends
2017 · Michael D. Richter, Cynthia S. Crowson, et al. · Arthritis Care & Research · 27
Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events
2019 · Caitrin M. Coffey, Michael D. Richter, et al. · The Journal of Rheumatology · 26
Clinical Presentations and Outcomes of Patients Receiving Immune Checkpoint Inhibitors Presenting to the Emergency Department
2021 · Richmond M. Castillo, Benjamin J. Sandefur, et al. · Mayo Clinic Proceedings Innovations Quality & Outcomes · 20
PDF
Thu0628 Immune-related Adverse Events Induced by Cancer Immunotherapies. Big Data Analysis of 13,051 Cases (immunocancer International Registry)
2019 · Manuel Ramos-Casals, Oliver Lambotte, et al. · Annals of the Rheumatic Diseases · 19
PDF
Removal of luminal content protects the small intestine during hemorrhagic shock but is not sufficient to prevent lung injury
2013 · Angelina E. Altshuler, Michael D. Richter, et al. · Physiological Reports · 19
PDF
Comparison of Biologic Discontinuation in Patients With Elderly‐Onset Versus Younger‐Onset Rheumatoid Arthritis
2019 · Michael D. Richter, Eric L. Matteson, et al. · ACR Open Rheumatology · 10
PDF
Thu0649 Phenotypic Clusters of Rheumatic/systemic Immune-related Adverse Events Induced by Cancer Immunotherapies (immunocancer International Registry)
2019 · Manuel Ramos-Casals, Oliver Lambotte, et al. · Annals of the Rheumatic Diseases · 8
PDF
Immunologic adverse events from immune checkpoint therapy
2020 · Michael D. Richter, Grant C. Hughes, et al. · Best Practice & Research Clinical Rheumatology · 6
Opioid use in patients with polymyalgia rheumatica.
2018 · Michael D Richter, Sara J Achenbach, et al. · PubMed · 3
Onset, duration, and clinical impact of immune-related adverse events in Hodgkin lymphoma.
2020 · Alexandra Higgins, Michael D. Richter, et al. · Journal of Clinical Oncology · 1
311 Retrospective Analysis of Patients Receiving Immune Checkpoint Inhibitors Presenting to the Emergency Department
2019 · R. Castillo, M. Richter, et al. · Annals of Emergency Medicine · 1
Asthma Education and Prevention Program
2012 · David B. Abrams, J. Rick Turner, et al. · Springer eBooks · 1
293. Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Effects
2019 · Caitrin Coffey, Michael Richter, et al. · Lara D. Veeken
PDF
SAT0588 Rheumatologic immune-related adverse effects of checkpoint inhibitor therapy: a single centrecohort of 29 patients
2018 · M.D. Richter, C.S. Crowson, et al. · Annals of the Rheumatic Diseases
PDF
Asthma
2012 · David B. Abrams, J. Rick Turner, et al. · Springer eBooks
Asthma Interventions
2012 · David B. Abrams, J. Rick Turner, et al. · Springer eBooks
Acute Condition
2012 · David B. Abrams, J. Rick Turner, et al. · Springer eBooks
[Acute abdomen: diagnostic approach].
2011 · Ulf Niemann, Andreas Imdahl, et al. · PubMed
Works count: 24
Citation count: 406
H-index: 8
I10-index: 8
Year
Topic
Type